Molecular Biomarkers for Diagnostics, Risk Stratification and Prediction of Chronic Heart Failure

Russian Journal of Cardiology - Russian Federation
doi 10.15829/1560-4071-2016-8-86-91
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Silicea - Poligraf, LLC

Related search

Role of Novel Cardiac Biomarkers for the Diagnosis, Risk Stratification, and Prognostication Among Patients With Heart Failure

Journal of Cardiology and Cardiovascular Medicine
2019English

Risk Stratification in Acute Heart Failure: Reply

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Usefulness of Combined Risk Stratification With Heart Rate and Systolic Blood Pressure in the Management of Chronic Heart Failure

Circulation Journal
MedicineCardiovascular MedicineCardiology
2013English

Strain Improves Risk Prediction Beyond Ejection Fraction in Chronic Systolic Heart Failure

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2014English

Coronary Risk Stratification of Patients With Newly Diagnosed Heart Failure

Open Heart
Cardiovascular MedicineCardiology
2019English

The Utility of Biomarker Risk Prediction Score in Patients With Chronic Heart Failure

Clinical Hypertension
2015English

126 Risk Stratification of Ambulatory Patients With Advanced Heart Failure Undergoing Evaluation for Heart Transplantation

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2012English

Risk Stratification for Death and All-Cause Hospitalization in Heart Failure Clinic Outpatients

American Heart Journal
Cardiovascular MedicineCardiology
2013English

Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy